RRC
50
-2
AMP
66
-3
CTAS
61
2
R
54
-2
PSA
55
2
DOV
69
-4
SE
47
-11
HRB
73
-2
RCL
61
-8
BSX
67
-2
SBUX
37
-2
EMN
65
-4
ROK
44
-6
ABBV
66
4
CMA
33
-3
SWN
32
-3
CFG
6
-4
URBN
56
-2
VRSK
84
2
FDX
51
-2
RRC
50
-2
AMP
66
-3
CTAS
61
2
R
54
-2
PSA
55
2
DOV
69
-4
SE
47
-11
HRB
73
-2
RCL
61
-8
BSX
67
-2
SBUX
37
-2
EMN
65
-4
ROK
44
-6
ABBV
66
4
CMA
33
-3
SWN
32
-3
CFG
6
-4
URBN
56
-2
VRSK
84
2
FDX
51
-2
Financhill
Back

SPDR S&P® North American Natural Res ETF Vs. Cytokinetics Industry Stock Comparison

Sell
12

NANR
SPDR S&P® North American Natural Res ETF

Last Price:
52.92
Seasonality Move:
-2.5%
Buy
55

CYTK
Cytokinetics

Last Price:
53.96
Seasonality Move:
7.55%
Sell
12
SPDR S&P® North American Natural Res ETF (NANR) is a Sell

Is SPDR S&P® North American Natural Res ETF a Buy, Sell or Hold?

  • The current SPDR S&P® North American Natural Res ETF [NANR] share price is $52.96. The Score for NANR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • NANR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NANR Stock Price Chart

What is SPDR S&P® North American Natural Res ETF's stock price today?

  • The SPDR S&P® North American Natural Res ETF share price today is $52.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NANR is experiencing slight buying pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

NANR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.8 Sell
Relative Strength Index (14 RSI): 35.08 Sell
Chaikin Money Flow: 2878 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.53 - 57.79) Sell
Bollinger Bands (100): (49.64 - 56.84) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.04 Sell
Relative Strength Index (14 RSI): 46.58 Sell
Chaikin Money Flow: 781761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.51 - 58.99) Sell
Bollinger Bands (100): (57.71 - 76.51) Sell

NANR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.22 Sell
20-day SMA: 55.85 Sell
50-day SMA: 56.21 Sell
200-day SMA: 52.24 Buy
8-day EMA: 54.14 Sell
20-day EMA: 55.21 Sell
50-day EMA: 55.28 Sell
200-day EMA: 53.14 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.47 Buy
20-day SMA: 52.83 Buy
50-day SMA: 60.85 Sell
200-day SMA: 55.3 Sell
8-day EMA: 53.07 Buy
20-day EMA: 54.08 Sell
50-day EMA: 58.8 Sell
200-day EMA: 57.11 Sell

SPDR S&P® North American Natural Res ETF Earnings Growth & NANR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.

SPDR S&P® North American Natural Res ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):